CYDY · OTC
It filed on time and stood behind its numbers. Of companies scoring zero, 4.0% were delisted, went bankrupt, restated or stopped filing within the following year.
Hover or tap a dot to see the filings behind that score.
d time period. . CytoDyn Inc. (the “Company”) was unable to file timely, without unreasonable effort and expense, its Form 10-Q for the fiscal quarter ended August 31, 2023 (the “Form 10-Q”), because its recently appointed independent registered public accounting firm requires additional time before completing its review of the Company’s financial statements for the fiscal quarter ended August 31, 2023. As noted in Part II(b) above, the Company anticipates that its Form 10-Q will be filed on or before the fifth calendar day following the prescribed due date
NT 10-Q, filed 2023-10-16 · auditor
2025-05-16auditor changed or resigned SEC →
2024-06-28auditor changed or resigned SEC →
2024-05-06auditor changed or resigned SEC →
d time period. . CytoDyn Inc. (the “Company”) was unable to file timely, without unreasonable effort and expense, its Form 10-Q for the fiscal quarter ended August 31, 2023 (the “Form 10-Q”), because its recently appointed independent registered public accounting firm requires additional time before completing its review of the Company’s financial statements for the fiscal quarter ended August 31, 2023. As noted in Part II(b) above, the Company anticipates that its Form 10-Q will be filed on or before the fifth calendar day following the prescribed due date
2023-10-10auditor changed or resigned SEC →
2023-09-25auditor changed or resigned SEC →
d time period. . CytoDyn, Inc. (the “Company”) was unable to file timely, without unreasonable effort and expense, its Annual Report on Form 10-K for the fiscal year ended May 31, 2023 (the “Form 10-K”), because its independent registered public accounting firm requires additional time before furnishing its required report regarding its audit of the Company’s financial statements for the fiscal year ended May 31, 2023, to evaluate the implications of an Order released by the Public Company Accounting Oversight Board (the “PCAOB”) on August 29, 2023, shortly before the Company’s filing deadline
2022-08-05accounts declared unreliable SEC →
d time period. . CytoDyn, Inc. (the “Company”) is unable to file, without unreasonable effort and expense, its Annual Report on Form 10-K for the fiscal year ended May 31, 2022 (the “Form 10-K”) because it requires additional time to complete the external audit of those statements included in the Form 10-K. The Company has experienced unexpected delays in completing the external audit due to the time required to evaluate alternative accounting treatment of non-cash expense related to settlement of convertible debt with equity instruments. The Form 10-K is expected to be filed not later than August 15, 2022.
2022-04-19auditor changed or resigned SEC →
reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.
Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.
See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.Every item above is a filing this company
made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not
investment advice